Business Context and Reporting Period
Company: Mega Matrix Inc.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Month of March 2026
Date of Filing: March 18, 2026
Subject: Change in Director Compensation for Dr. Yunhao Chen.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The report is limited to a specific corporate governance transaction regarding executive compensation.
Material Changes
The filing details a material amendment to the compensation agreement for Dr. Yunhao Chen, an independent director, effective March 16, 2026:
- Cancellation of Equity: The original Award Agreement granting 24,000 restricted share units (RSUs) was terminated. As of the filing date, 6,000 RSUs had vested and 18,000 remained unvested; all unvested shares were cancelled.
- Adjustment to Cash Compensation: Monthly cash compensation was increased from $3,000 to $5,000.
- Retroactive Application: The new monthly fee is effective retroactively to January 1, 2026.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, market outlook, management commentary on operations, or discussion of risks and contingencies. The document strictly reports the execution of the Director Agreement Amendment.
Investor Verification Checklist
- Verify the total retroactive cash compensation adjustment for Dr. Chen from January 1, 2026, to the current date.
- Confirm the accounting treatment for the cancellation of the 18,000 unvested restricted share units.
- Review the full text of the Amendment to the Director Agreement filed as Exhibit 10.1 for additional terms.
- Assess the impact of this compensation change on the company's total director compensation expense for the fiscal year.